COMMUNIQUÉS West-GlobeNewswire

-
Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
17/06/2025 -
LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets
17/06/2025 -
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
17/06/2025 -
Alira Health Launches Patient Engagement Certification for Life Sciences Organizations
17/06/2025 -
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
17/06/2025 -
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
17/06/2025 -
Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
17/06/2025 -
Project Sunshine Announces "Longest Day of Play" Fundraising Campaign Planned for June 20th Alongside Refreshed Visual Identity
17/06/2025 -
BioRestorative Announces Share Repurchase Program
17/06/2025 -
Prime Biome Gummy: Examining the Science and Safety of a Legal Gut-Skin Health Formula
17/06/2025 -
FDA Grants Orphan Drug Designation to Medicovestor’s First-in-Class ADC for Pancreatic Cancer
17/06/2025 -
USAHS & The Brain Center Unite to Support Dementia Caregivers with Hands-On Course
17/06/2025 -
Lauréat de l’appel à projet Biothérapies et Bioproduction, du plan France 2030, EVerZom reçoit un financement de l’Etat de 3 millions d’euros pour industrialiser sa technologie de bioproduction d’exosomes
17/06/2025 -
Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology
17/06/2025 -
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
17/06/2025 -
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
17/06/2025 -
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients
17/06/2025 -
Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
17/06/2025 -
Tariffs and U.S.-Canada relations are the top financial concern for seniors: new research from HOOPP and Abacus Data
17/06/2025
Pages